DOI QR코드

DOI QR Code

Aberrant Expression of CCAT1 Regulated by c-Myc Predicts the Prognosis of Hepatocellular Carcinoma

  • Zhu, Hua-Qiang (Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University) ;
  • Zhou, Xu (Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University) ;
  • Chang, Hong (Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University) ;
  • Li, Hong-Guang (Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University) ;
  • Liu, Fang-Feng (Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University) ;
  • Ma, Chao-Qun (Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University) ;
  • Lu, Jun (Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University)
  • 발행 : 2015.08.03

초록

Background: CCAT1 has been reported to be linked with pathogenesis of malignancies including colon cancer and gastric cancer. However, the regulatory effect of CCAT1 in hepatocellular carcinoma (HCC) remains unclear. The purpose of this research was to identify any role of CCAT1 in the progression of HCC. Materials and Methods: Real time-PCR was performed to test the relative expression of CCAT1 in HCC tissues. A computation screen of CCAT1 promoter was conducted to search for transcription-factor-binding sites. The association of c-Myc with CCAT1 promoter in vivo was tested by Pearson correlation analysis and chromatin immunoprecipitation assay. Additionally, Kaplan-Meier analysis and Cox proportional hazards analyses were performed. Results: c-Myc directly binds to the E-box element in the promoter region of CCAT, and when ectopically expressed increases promoter activity and expression of CCAT1. Moreover, Kaplan-Meier analysis demonstrated that the patients with low expression of CCAT1 demonstrated better overall and relapse-free survival compared with the high expression group. Cox proportional hazards analyses showed that CCAT1 expression was an independent prognostic factor for HCC patients. Conclusions: The findings demonstrated CCAT1, acting as a potential biomarker in predicting the prognosis of HCC, is regulated by c-Myc.

키워드

참고문헌

  1. Alaiyan B, Ilyayev N, Stojadinovic A, et al (2013). Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence. BMC Cancer, 13, 196. https://doi.org/10.1186/1471-2407-13-196
  2. Arase M, Horiguchi K, Ehata S, et al (2014). Transforming growth factor-beta-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells. Cancer Sci, 105, 974-82. https://doi.org/10.1111/cas.12454
  3. Bao X, Wu H, Zhu X, et al (2015). The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res, 25, 80-92. https://doi.org/10.1038/cr.2014.165
  4. Cai JB, Shi GM, Dong ZR, et al (2014). Ubiquitin-specific protease 7 accelerates p14 degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatol, [Epub ahead of print].
  5. Cao C, Sun J, Zhang D, et al (2015). The Long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of beta-catenin in HCC cells. Gastroenterol, 148, 415-26 e18. https://doi.org/10.1053/j.gastro.2014.10.012
  6. Chen M, Therneau T, Orsini LS, et al (2011). Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma. BMC Gastroenterol, 11, 53. https://doi.org/10.1186/1471-230X-11-53
  7. Engreitz JM, Pandya-Jones A, McDonel P, et al (2013). The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science, 341, 1237973. https://doi.org/10.1126/science.1237973
  8. Fang TT, Sun XJ, Chen J, et al (2014). Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential. Asian Pac J Cancer Prev, 15, 10513-24.
  9. Flemming JA, Yang JD, Vittinghoff E, et al (2014). Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer, 120, 3485-93. https://doi.org/10.1002/cncr.28832
  10. Gibb EA, Brown CJ, Lam WL (2011). The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 10, 38. https://doi.org/10.1186/1476-4598-10-38
  11. Haerty W, Ponting CP (2015). Unexpected selection to retain high GC content and splicing enhancers within exons of multiexonic lncRNA loci. RNA, [Epub ahead of print].
  12. He X, Tan X, Wang X, et al (2014). C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol, 35, 12181-8. https://doi.org/10.1007/s13277-014-2526-4
  13. Hu X, Feng Y, Zhang D, et al (2014). A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell, 26, 344-57. https://doi.org/10.1016/j.ccr.2014.07.009
  14. Kallen AN, Zhou XB, Xu J, et al (2013). The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell, 52, 101-12. https://doi.org/10.1016/j.molcel.2013.08.027
  15. Kam Y, Rubinstein A, Naik S, et al (2014). Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons. Cancer Lett, 352, 90-6. https://doi.org/10.1016/j.canlet.2013.02.014
  16. Li GJ, Harrison TJ, Yang JY, et al (2013). Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China. Liver Int, 33, 936-43. https://doi.org/10.1111/liv.12142
  17. Li Z, Rana TM (2014). Decoding the noncoding: prospective of lncRNA-mediated innate immune regulation. RNA Biol, 11, 979-85. https://doi.org/10.4161/rna.29937
  18. Ma MZ, Chu BF, Zhang Y, et al (2015). Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis, 6, 1583. https://doi.org/10.1038/cddis.2014.541
  19. Mizrahi I, Mazeh H, Grinbaum R, et al (2015). Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach. J Cancer, 6, 105-10. https://doi.org/10.7150/jca.10568
  20. Spizzo R, Almeida MI, Colombatti A, et al (2012). Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene, 31, 4577-87. https://doi.org/10.1038/onc.2011.621
  21. Sun M, Liu XH, Lu KH, et al (2014). EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis, 5, 1298. https://doi.org/10.1038/cddis.2014.256
  22. Uva P, Da Sacco L, Del Corno M, et al (2013). Rat mir-155 generated from the lncRNA Bic is 'hidden' in the alternate genomic assembly and reveals the existence of novel mammalian miRNAs and clusters. RNA, 19, 365-79. https://doi.org/10.1261/rna.035394.112
  23. Wu SC, Kallin EM, Zhang Y (2010). Role of H3K27 methylation in the regulation of lncRNA expression. Cell Res, 20, 1109-16. https://doi.org/10.1038/cr.2010.114
  24. Xiang JF, Yin QF, Chen T, et al (2014). Human colorectal cancerspecific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res, 24, 513-31. https://doi.org/10.1038/cr.2014.35
  25. Xing Z, Lin A, Li C, et al (2014). lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell, 159, 1110-25. https://doi.org/10.1016/j.cell.2014.10.013
  26. Yang F, Xue X, Bi J, et al (2013). Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol, 139, 437-45. https://doi.org/10.1007/s00432-012-1324-x
  27. Zhu Z, Gao X, He Y, et al (2012). An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res, 72, 6163-72. https://doi.org/10.1158/0008-5472.CAN-12-0010

피인용 문헌

  1. Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review) vol.36, pp.3, 2016, https://doi.org/10.3892/or.2016.4929
  2. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5227-3
  3. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers vol.49, pp.3, 2016, https://doi.org/10.1111/cpr.12252
  4. Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis vol.12, pp.6, 2017, https://doi.org/10.1371/journal.pone.0179346
  5. CCAT1: an oncogenic long noncoding RNA in human cancers vol.143, pp.4, 2017, https://doi.org/10.1007/s00432-016-2268-3
  6. Long non-coding RNA CCAT1 is overexpressed in oral squamous cell carcinomas and predicts poor prognosis vol.6, pp.4, 2017, https://doi.org/10.3892/br.2017.876
  7. Persistent Exposure to Porphyromonas gingivalis Promotes Proliferative and Invasion Capabilities, and Tumorigenic Properties of Human Immortalized Oral Epithelial Cells vol.7, pp.2235-2988, 2017, https://doi.org/10.3389/fcimb.2017.00057
  8. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells vol.9, pp.4, 2017, https://doi.org/10.3390/cancers9040038
  9. Long noncoding RNA HOTTIP promotes endothelial cell proliferation and migration via activation of the Wnt/β-catenin pathway pp.07302312, 2017, https://doi.org/10.1002/jcb.26448
  10. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a pp.09607722, 2017, https://doi.org/10.1111/cpr.12409
  11. Current Status of Long Non-Coding RNAs in Human Breast Cancer vol.17, pp.9, 2016, https://doi.org/10.3390/ijms17091485
  12. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets vol.140, pp.9, 2016, https://doi.org/10.1002/ijc.30546
  13. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis vol.24, pp.5, 2018, https://doi.org/10.3748/wjg.v24.i5.549
  14. CX-3543 Promotes Cell Apoptosis through Downregulation of CCAT1 in Colon Cancer Cells vol.2018, pp.2314-6141, 2018, https://doi.org/10.1155/2018/9701957
  15. Identification of abnormally expressed lncRNAs induced by PM2.5 in human bronchial epithelial cells vol.38, pp.5, 2018, https://doi.org/10.1042/BSR20171577
  16. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression vol.9, pp.1, 2018, https://doi.org/10.1038/s41467-018-06081-9
  17. : Roles and functions in human cancers pp.00219541, 2019, https://doi.org/10.1002/jcp.28176